How do we best measure the clinical benefit of a structure-modifying osteoarthritis drug?

Publisher Website

31 December 2004

journal article
research article
Published by Elsevier in Osteoarthritis and Cartilage

Vol. 12, 61-62
https://doi.org/10.1016/j.joca.2003.09.006

Abstract

No abstract available

Keywords

This publication has 2 references indexed in Scilit:

Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
Arthritis & Rheumatism, 2001
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
The Lancet, 2001